Scaling Radioligand Therapy: 3 Essential Strategies From Inside The Ecosystem
Radioligand therapies have gone mainstream. Eli Lilly’s $1.4 billion acquisition of Point Biopharma and Novartis’s $23 billion U.S. infrastructure investment ...
Radioligand therapies have gone mainstream. Eli Lilly’s $1.4 billion acquisition of Point Biopharma and Novartis’s $23 billion U.S. infrastructure investment ...
In a typical display of optimism, U.S. envoy Steve Witkoff described the latest American plan as a realistic start. He ...
In a corner of the internet where paying off a mortgage early earns you digital applause and a fully funded ...
There's a growing need for individuals and organisations to effectively harness the power of technology in the workplace. He, she, ...
As the year comes to a close, compensation professionals are sounding the alarm on the evolving expectations of workers in ...
As staff recruitment and retention remain major challenges in the healthcare industry, how can healthcare organizations ensure staff members feel ...
Copyright © 2024 The Israel Chronicle News.
The Israel Chronicle News is not responsible for the content of external sites.